Who is sponsoring NCT04983186?

NCT04983186 is sponsored by University Hospital, Ghent.

What drugs are being tested in NCT04983186?

Interventions in NCT04983186: Wearable sensor and smartphone application.

What condition does NCT04983186 study?

NCT04983186 studies Migraine, Cluster Headache.

Is NCT04983186 still recruiting?

NCT04983186 is currently completed. Last updated 6 February 2024.

Last reviewed 2024-02-06 · How we verify

NCT04983186: MBRAIN-21

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

mBrain-21 : a Three-month Study on Context-awareness, Physiological Monitoring, and Machine Learning in Migraine and Cluster Headache

Completed NA Last updated 6 February 2024

What this trial tests

NA trial testing Wearable sensor and smartphone application in Migraine in 30 participants. Completed in 7 September 2023.

Timeline

19 July 2021

Primary endpoint
7 September 2023

7 September 2023

Quick facts

Lead sponsor	University Hospital, Ghent
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	diagnostic
Enrollment	30
Start date	19 July 2021
Primary completion	7 September 2023
Estimated completion	7 September 2023
Sites	1 location across Belgium

Drugs / interventions tested

Wearable sensor and smartphone application

Conditions studied

Migraine — all drugs for Migraine →
Cluster Headache — all drugs for Cluster Headache →

Sponsor

University Hospital, Ghent

Who can join

Adults 18 to 65, any sex, with Migraine or Cluster Headache. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study collects data from migraine and cluster headache patients during a three-month study. Contextual data (e.g. location or smartphone usage) and physiological variables will be used to assist machine learning algorithms in making predictions on activity, stress and sleep in patients with migraine or cluster headache.

Publications & conference data

2 peer-reviewed publications reference this trial (live from Europe PMC):

Analysis of free-living daytime movement in patients with migraine with access to acute treatment.
Van Der Donckt J, Vandenbussche N, De Brouwer M, Steenwinckel B, et al · · 2025 · cited 4× · PMID 39948510 · DOI 10.1186/s10194-025-01971-y
Tracking Migraine Symptoms: A Longitudinal Comparison of Smartphone-Based Headache Diaries and Clinical Interviews.
Vandenbussche N, Van Der Donckt J, De Brouwer M, Steenwinckel B, et al · · 2025 · PMID 40137454 · DOI 10.3390/neurolint17030033

Verify or expand the search:

Other recruiting trials for Migraine

Currently open trials in the same condition.

NCT07419607 — MIGRAFIT: Evaluating a Group Therapy Program Combining Physical Activity, Progressive Muscle Relaxation and Psychoeducat · NA · recruiting
NCT07487701 — Migraine Prevention With the Remote Electrical Neuromodulation (REN) Wearable: A Real-world Evidence Study · NA · active not recruiting
NCT07343427 — Impact of GON PRF on Central Sensitization in Migraine Patients · NA · active not recruiting
NCT07336056 — Nerivio Efficacy Under High-Frequency Use · Phase 4 · active not recruiting
NCT07385755 — Desvenlafaxine for Preventive Treatment of Frequent Migraines · NA · active not recruiting

Other University Hospital, Ghent trials

Trials by the same sponsor.

NCT07584486 — Development of a New Simplified Tool to Predict LNPCPs Histology and Assess the Risk of Submucosal Invasive Cancer. The · NA · not yet recruiting
NCT07327450 — Coaching Doctors and Nurses to Improve Ethical Decision-making in Team · NA · not yet recruiting
NCT07402057 — Implementation and Evaluation of a Program Aimed at Facilitating Palliative Care Conversations · NA · recruiting
NCT07387328 — Validation of New sEMG Electrode Placement Guidelines for the Triceps Surae in Post-stroke Individuals. · not yet recruiting
NCT07237399 — Percutaneous Thermo-ablation for the Treatment of Prostate Cancer Oligometastatasis (TA-P-OLIM) · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04983186 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University Hospital, Ghent
Last refreshed: 6 February 2024

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04983186.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing